Amantadine NDC 60687-422

NDC codes

FDA NDC Directory

Product NDC (as listed)60687-422Labeler and product segments. Claims need a package NDC.

Product NDC at billing width60687-0422Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
60687-422-01	60687042201	100 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-422-01) / 1 CAPSULE in 1 BLISTER PACK (60687-422-11)Marketed from May 21, 2019

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Amantadine
Generic name (nonproprietary): amantadine
Active ingredients: Amantadine hydrochloride — 100 mg/1
Dosage form: Capsule
Route: Oral
Labeler: American Health Packaging
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 208966
Marketing start: May 1, 2019
Listing expires: Dec 31, 2027
Other FDA classes: M2 Protein Inhibitors (Mechanism)
Identifiers: Product ID 60687-422_54ef7db5-cbe4-e871-e063-6394a90ab56bSPL ID 54ef7db5-cbe4-e871-e063-6394a90ab56bSPL set ID 5119801d-a5cb-4adf-96b2-08cc3a0ba594RxCUI 849389UNII M6Q1EO9TD0
Pharmacologic class: Influenza A M2 Protein Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N460687042201 followed by a unit qualifier and the quantity

Package 60687-0422-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 23, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Amantadine hydrochloride capsules are indicated for the prophylaxis and treatment of signs and symptoms of infection caused by various strains of influenza A virus. Amantadine hydrochloride capsules are also indicated in the treatment of parkinsonism and drug-induced extrapyramidal reactions. Influenza A Prophylaxis Amantadine hydrochloride capsules are indicated for chemoprophylaxis against signs and symptoms of influenza A virus infection. Because amantadine does not completely prevent the host immune response to influenza A infection, individuals who take this drug may still develop immune responses to natural disease or vaccination and may be protected when later ex…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 208966

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 208966
Product	Strength	Form · route	Labeler	Product NDC
amantadine	Amantadine hydrochloride 100 mg/1	CapsuleOral	Alembic Pharmaceuticals Limited	46708-246
amantadine	Amantadine hydrochloride 100 mg/1	CapsuleOral	Alembic Pharmaceuticals Inc.	62332-246